DE602005016417D1 - Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila - Google Patents

Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila

Info

Publication number
DE602005016417D1
DE602005016417D1 DE602005016417T DE602005016417T DE602005016417D1 DE 602005016417 D1 DE602005016417 D1 DE 602005016417D1 DE 602005016417 T DE602005016417 T DE 602005016417T DE 602005016417 T DE602005016417 T DE 602005016417T DE 602005016417 D1 DE602005016417 D1 DE 602005016417D1
Authority
DE
Germany
Prior art keywords
legionella pneumophila
vintro
infections
prevention
insulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005016417T
Other languages
English (en)
Inventor
Jean-Philippe Arie
Camille Cyncynatus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Claude Bernard Lyon 1 UCBL
InGen BioSciences
Original Assignee
Universite Claude Bernard Lyon 1 UCBL
InGen BioSciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0407114A external-priority patent/FR2872289B1/fr
Priority claimed from FR0408714A external-priority patent/FR2874025B1/fr
Priority claimed from FR0413063A external-priority patent/FR2878861B1/fr
Application filed by Universite Claude Bernard Lyon 1 UCBL, InGen BioSciences filed Critical Universite Claude Bernard Lyon 1 UCBL
Publication of DE602005016417D1 publication Critical patent/DE602005016417D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005016417T 2004-06-29 2005-06-21 Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila Active DE602005016417D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0407114A FR2872289B1 (fr) 2004-06-29 2004-06-29 Utilisation de la proteine g5 dans le diagnostic in vitro d'infection a legionella pneumophila
FR0408714A FR2874025B1 (fr) 2004-08-06 2004-08-06 Nouvelles proteines permettant, notamment, la mise en evidence in vitro et la prevention des infections a legionella pneumophila
FR0413063A FR2878861B1 (fr) 2004-12-08 2004-12-08 Nouvelles proteines permettant la mise en evidence in vitro et la prevention des infections a legionella pneumophila
PCT/FR2005/001548 WO2006010805A2 (fr) 2004-06-29 2005-06-21 Nouveaux polypeptides pour la mise en evidence in vitro et la prevention des infections a legionella pneumophila

Publications (1)

Publication Number Publication Date
DE602005016417D1 true DE602005016417D1 (de) 2009-10-15

Family

ID=35169467

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016417T Active DE602005016417D1 (de) 2004-06-29 2005-06-21 Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila

Country Status (4)

Country Link
EP (1) EP1769249B1 (de)
AT (1) ATE441865T1 (de)
DE (1) DE602005016417D1 (de)
WO (1) WO2006010805A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2895519B1 (fr) * 2005-12-28 2008-12-19 Abag Sa Utilisation de la proteine 5e2 dans le diagnostic in vitro d'infection a legionella pneumophila
FR2930646B1 (fr) * 2008-04-29 2012-09-07 Abag Detection, in vitro, d'anticorps produits a la suite d'une infection a legionella pneumophila
EP2586789A1 (de) * 2011-08-11 2013-05-01 InGen Biosciences Verfahren zur Diagnose von gramnegativen Infektionen
US8785145B2 (en) 2011-08-11 2014-07-22 Ingen Biosciences Method for diagnosing gram-negative infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610203D0 (en) * 1986-04-25 1986-05-29 Technology Licence Co Ltd Monoclonal antibodies
AU4337099A (en) * 1998-06-11 1999-12-30 St. Jude Children's Research Hospital Zmpb, a new determinant of virulence for (streptococcus pneumoniae), vaccine derived therefrom and uses thereof

Also Published As

Publication number Publication date
WO2006010805A2 (fr) 2006-02-02
WO2006010805A3 (fr) 2006-06-22
EP1769249A2 (de) 2007-04-04
ATE441865T1 (de) 2009-09-15
EP1769249B1 (de) 2009-09-02

Similar Documents

Publication Publication Date Title
NZ627111A (en) Variants of activin iib receptor polypeptides and uses thereof
EP1893229A4 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
NZ591855A (en) Novel immunotherapy against several tumors including neuronal and brain tumors
NO20063026L (no) Antistoffer
WO2007094916A3 (en) Non-natural amino acid polypeptides having modulated immunogenicity
NZ609216A (en) Anticancer fusion protein
ATE453663T1 (de) Zusammensetzungen von für pathogene stämme spezifischen polypeptiden und deren verwendung als impfstoffe und in der immuntherapie
RS51325B (sr) Polipeptidi koji imaju antimikrobno dejstvo i polinukleotidi koji ih kodiraju
WO2008087224A3 (en) Mutated netrin 4, fragments thereof and uses thereof as drugs
DE602005016417D1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
MX2010005816A (es) Epítopos de péptido de stat3.
DK1913020T3 (da) Immunogene konstrukter
DE602005018369D1 (de) Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen
CY1111630T1 (el) Παραγωγα κυτοκινων
WO2018074498A8 (ja) リムルス属由来の組換え蛋白質及びこれをコードするｄｎａ
WO2004041859A3 (fr) Fragments peptidiques du facteur harp inhibant l'angiogenese
WO2009083968A8 (en) Novel protein
DE602007006493D1 (de) Peptide mit proliferationshemmender wirkung
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
WO2006125914A3 (fr) Utilisation de la protéine h11 dans le diagnostic in vitro d'infections à streptococcus pyogenes.
ATE443715T1 (de) Polypeptide aus haemophilus influenza
SE0001988D0 (sv) Novel polypeptides and use thereof
TH87509B (th) พอลินิวคลีโอไทด์ของ Haemophilus parasuis และการใช้งานสารนี้
DE602007009797D1 (de) Antitumorheilmittel, Medikament, Zusammensetzung und Verwendung davon
NZ603077A (en) Biological materials and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition